How Do Colorectal Cancers Arise Despite Surveillance?
How Do Colorectal Cancers Arise Despite Surveillance?
批准号:
7256986
负责人:
Darryl K Shibata
金额:
$23.26万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-01 至 2010-06-30
关键词:
AXIN2 geneAgeBAX geneBRAF geneBax proteinBiologyCancer PatientClinicalColorectalColorectal CancerCountDNADevelopmentEmerging TechnologiesFailureGenesGeneticGerm-Line MutationHereditary Nonpolyposis Colorectal NeoplasmsHistologicIndividualKRAS2 geneMalignant NeoplasmsMedical SurveillanceMicrosatellite RepeatsMismatch RepairMolecularMutationNumbersPatientsPatternPolypectomyPreventionRiskScreening for cancerSomatic MutationSurveillance ProgramTimeadenomaage differencepreventtumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Colorectal cancers are widely believed to develop through an adenoma-cancer sequence. By this paradigm, all cancers should be preventable with surveillance and polypectomy. However, in most surveillance studies, some cancers inevitably appear only a few years after negative clinical examinations. It is uncertain how such "interval" cancers appear, but either an adenoma was missed during the last "negative" examination, or there was an unexpected "rapid" mode of progression. A large number of such interval cancers have been found during an ongoing clinical surveillance program of high risk individuals with germline mutations in DNA mismatch repair genes (MMR), or hereditary nonpolyposis colorectal cancer (HNPCC). These interval cancers provide unique opportunities to rigorously understand why prevention fails. The key emerging technology is a new capability that infers time from cancer mutations. A molecular tumor clock can quantitatively infer times since MMR loss, and ages of final cancer expansions---the more mutations in a cancer, the greater these intervals. Distinguishing between failure from inadequate surveillance ("missed adenomas"), and failure due to the unique biology of HNPCC colorectal cancers ("rapid histologic or genetic progression"), is critical for the development of more effective strategies to prevent and treat colorectal cancer.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Older individuals appear to acquire mitotically older colorectal cancers.
老年人似乎会患上有丝分裂较老的结直肠癌。
DOI:
10.1002/path.2506
发表时间:
2009
期刊:
The Journal of pathology
影响因子:
--
作者:
[Woo,Yen-Jung, Siegmund,KimberlyD, Tavaré,Simon, Shibata,Darryl]
通讯作者:
Shibata,Darryl
Photolithographic Tumor DNA Isolation
-
批准号:10670402
-
项目类别:
-
资助金额:$18.14万
-
财政年份:2022
-
负责人:Darryl K Shibata
-
依托单位:
Photolithographic Tumor DNA Isolation
-
批准号:10495070
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2022
-
负责人:Darryl K Shibata
-
依托单位:
Project 2: Normal Cell Evolution
-
批准号:10392868
-
项目类别:
-
资助金额:$50.72万
-
财政年份:2018
-
负责人:Darryl K Shibata
-
依托单位:
Project 3: Neoplastic Cell Evolution
-
批准号:10392869
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2018
-
负责人:Darryl K Shibata
-
依托单位:
"Born to be Bad": Is Abnormal Cell Mobility Already Present At Initiation?
-
批准号:8686657
-
项目类别:
-
资助金额:$21.46万
-
财政年份:2014
-
负责人:Darryl K Shibata
-
依托单位:
How Do NSAIDs Prevent Colorectal Cancer
-
批准号:8384151
-
项目类别:
-
资助金额:$22.32万
-
财政年份:2012
-
负责人:Darryl K Shibata
-
依托单位:
How Do NSAIDs Prevent Colorectal Cancer
-
批准号:8545125
-
项目类别:
-
资助金额:$16.18万
-
财政年份:2012
-
负责人:Darryl K Shibata
-
依托单位:
Tumor Diversity As A Biomarker For Colorectal Cancer
-
批准号:7874806
-
项目类别:
-
资助金额:$21.17万
-
财政年份:2010
-
负责人:Darryl K Shibata
-
依托单位:
Tumor Diversity As A Biomarker For Colorectal Cancer
-
批准号:8050151
-
项目类别:
-
资助金额:$17.09万
-
财政年份:2010
-
负责人:Darryl K Shibata
-
依托单位:
A Cancer Evolution Space-Time Machine
-
批准号:7802564
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2009
-
负责人:Darryl K Shibata
-
依托单位:
How Do Colorectal Cancers Arise Despite Surveillance?
-
批准号:6859788
-
项目类别:
-
资助金额:$30.91万
-
财政年份:2005
-
负责人:Darryl K Shibata
-
依托单位:
How Do Colorectal Cancers Arise Despite Surveillance?
-
批准号:7105101
-
项目类别:
-
资助金额:$23.96万
-
财政年份:2005
-
负责人:Darryl K Shibata
-
依托单位:
HUMAN COLON STEM CELL AND CRYPT DYNAMICS
-
批准号:6524807
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2001
-
负责人:Darryl K Shibata
-
依托单位:
Fixing Fixed DNA
-
批准号:6515082
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2001
-
负责人:Darryl K Shibata
-
依托单位:
HUMAN COLON STEM CELL AND CRYPT DYNAMICS
-
批准号:6446703
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2001
-
负责人:Darryl K Shibata
-
依托单位:
Fixing Fixed DNA
-
批准号:6334404
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2001
-
负责人:Darryl K Shibata
-
依托单位:
MOUSE MODELS OF EARLY INTESTINAL NEOPLASIA
-
批准号:6342133
-
项目类别:
-
资助金额:$28.13万
-
财政年份:1999
-
负责人:Darryl K Shibata
-
依托单位:
MOUSE MODELS OF EARLY INTESTINAL NEOPLASIA
-
批准号:2742755
-
项目类别:
-
资助金额:$28.38万
-
财政年份:1999
-
负责人:Darryl K Shibata
-
依托单位:
Mouse Models of Early Intestinal Neoplasia
-
批准号:7046097
-
项目类别:
-
资助金额:$30.63万
-
财政年份:1999
-
负责人:Darryl K Shibata
-
依托单位:
MOUSE MODELS OF EARLY INTESTINAL NEOPLASIA
-
批准号:6489182
-
项目类别:
-
资助金额:$28.82万
-
财政年份:1999
-
负责人:Darryl K Shibata
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: